Arcutis Biotherapeutics, Inc. (ARQT) has a market capitalization of $3.11B and trades at $25.09. The 52-week range is 11.86-31.77.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -193, Earnings Per Share (EPS) of $-0.13, annual revenue of $376.07M.
The stock has a beta of 1.77, operates in the Healthcare sector.
